Walgreens Boots Alliance Inc (WBA) : Jones Collombin Investment Counsel Inc reduced its stake in Walgreens Boots Alliance Inc by 6.32% during the most recent quarter end. The investment management company now holds a total of 131,824 shares of Walgreens Boots Alliance Inc which is valued at $10,723,882 after selling 8,892 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Jul 20, 2016.Walgreens Boots Alliance Inc makes up approximately 3.09% of Jones Collombin Investment Counsel Inc’s portfolio.
Other Hedge Funds, Including , Capital One National Association boosted its stake in WBA in the latest quarter, The investment management firm added 138 additional shares and now holds a total of 6,332 shares of Walgreens Boots Alliance Inc which is valued at $522,453. Walgreens Boots Alliance Inc makes up approx 0.04% of Capital One National Association’s portfolio.Douglass Winthrop Advisors boosted its stake in WBA in the latest quarter, The investment management firm added 850 additional shares and now holds a total of 46,455 shares of Walgreens Boots Alliance Inc which is valued at $3,798,625. Walgreens Boots Alliance Inc makes up approx 0.28% of Douglass Winthrop Advisors’s portfolio.Howland Capital Management reduced its stake in WBA by selling 4,437 shares or 1.5% in the most recent quarter. The Hedge Fund company now holds 292,248 shares of WBA which is valued at $23,905,886. Walgreens Boots Alliance Inc makes up approx 2.23% of Howland Capital Management’s portfolio.
Walgreens Boots Alliance Inc opened for trading at $82.37 and hit $82.64 on the upside on Wednesday, eventually ending the session at $82.51, with a gain of 0.36% or 0.3 points. The heightened volatility saw the trading volume jump to 49,19,258 shares. Company has a market cap of $89,302 M.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.